Protagenic Therapeutics, Inc.

NasdaqCM:PTIX Stock Report

Mkt Cap: US$9.7m

Protagenic Therapeutics Management

How experienced are the management team and are they aligned to shareholders interests?

18.3yrs

Average management tenure


CEO

Protagenic Therapeutics has no CEO, or we have no data on them.


Leadership Team

NamePositionTenureCompensationOwnership
Garo Armen
Co-Founder & Executive Chairman of the Boardno datano data17.09%
$ 1.7m
Alexander Arrow
CFO & Secretary6.92yrsUS$136.54k0.88%
$ 84.7k
Andrew Slee
Chief Operating Officerno datano datano data
Robert Stein
Chief Medical Officer & Directorno datano datano data
David Lovejoy
Chief Scientific Officer18.33yrsno data0.86%
$ 83.3k

18.3yrs

Average Tenure

70yo

Average Age

Experienced Management: PTIX's management team is seasoned and experienced (18.3 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Garo Armen
Co-Founder & Executive Chairman of the Boardno datano data17.09%
$ 1.7m
Robert Stein
Chief Medical Officer & Director6.92yrsno datano data
Timothy Wright
Independent Director0.17yrno datano data
Brian Corvese
Independent Director5.5yrsUS$118.75kno data
Khalil Barrage
Independent Directorno dataUS$243.75k2.37%
$ 229.6k
Dalia Barsyte
Member of Scientific & Clinical Advisory Boardno datano datano data
Jennifer Buell
Non-Independent Director2.5yrsno datano data

4.0yrs

Average Tenure

64yo

Average Age

Experienced Board: PTIX's board of directors are considered experienced (4 years average tenure).